Endoscopic Submucosal Dissection (ESD) Of A Neuroendocrine Tumor Of The Duodenal Bulb Using Dual-Knife-J And Traction With Rubberband/Clip Technique

2021 ◽  
Author(s):  
T Beyna
2016 ◽  
Vol 111 (6) ◽  
pp. 764
Author(s):  
João Santos-Antunes ◽  
Margarida Marques ◽  
Patrícia Andrade ◽  
Filipe Vilas-Boas ◽  
Andreia Albuquerque ◽  
...  

Endoscopy ◽  
2016 ◽  
Vol 48 (S 01) ◽  
pp. E67-E68 ◽  
Author(s):  
Shunsuke Yoshii ◽  
Yoshito Hayashi ◽  
Takahiro Matsui ◽  
Kenji Aoi ◽  
Yoshiki Tsujii ◽  
...  

2021 ◽  
Vol 5 (5) ◽  
Author(s):  
Nannan Zhao ◽  
Nan Li

Objective: To study the therapeutic effect of endoscopic submucosal dissection and mucosal resection on gastric neuroendocrine tumor. Methods: A hundred patients with gastric neuroendocrine tumor that were treated in the Affiliated Hospital of Chifeng University from January 2016 to May 2021 were randomly selected for this research. They were divided into two groups, which were the control group (endoscopic mucosal resection) and the study group (endoscopic submucosal dissection), by the digital table method. The curative effects of the two groups were observed and compared. Results: Before operation, there were no significant differences in serum CgA, TNF-?, and IL-6 between the two groups, p > 0.05. After surgical treatment, the operation time and hospital stay of the patients in the study group were shorter than those in the control group, the amount of surgical bleeding was also less compared to the control group, and the complete tumor resection rate was higher than that in the control group (p < 0.05); the levels of IL-6 and CgA of the study group were lower than those in the control group, while the levels of TNF-? were higher than those of the control group, p < 0.05; the postoperative complication rate of the study group was lower than that of the reference group (p < 0.05). Conclusion: Endoscopic submucosal dissection is more effective for gastric neuroendocrine tumors. The resection rate of the tumor is high, and the operation risk is low.


2019 ◽  
Vol 51 ◽  
pp. e208-e209
Author(s):  
C. Genco ◽  
F. Mazza ◽  
D. Stradella ◽  
E. Armellini ◽  
M. Ballarè ◽  
...  

2016 ◽  
Vol 29 (4) ◽  
pp. 176-179
Author(s):  
Pawel Bojar ◽  
Jaroslaw Swatek ◽  
Jaroslaw Drabko ◽  
Katarzyna Golec ◽  
Anna Ostrowska ◽  
...  

Abstract A case of a 59-year-old male patient with gastric neuroendocrine tumor which was misdiagnosed as adenocarcinoma, is presented. Herein, primary diagnosis was made due to the similarity of endoscopic pictures of both diseases and dues to the inappropriate interpretation of a small biopsy sample. The patient was qualified for endoscopic submucosal dissection. Microscopic examination of whole lesion, supplemented by immmunohistochemical reactions (chromogranin A, synaptophysin, cytokeratins 7 and 20, Ki67) revealed gastric neuroendocrine tumor (NET) G2. The lesson learnt is that to provide effective treatment to the patient, it is necessary to use all available methods to make a proper diagnosis and to distinguish the suspected disease from others with similar features.


VideoGIE ◽  
2019 ◽  
Vol 4 (12) ◽  
pp. 570-573 ◽  
Author(s):  
Borathchakra Oung ◽  
Thomas Walter ◽  
Valérie Hervieu ◽  
Jérémie Jacques ◽  
Mathieu Pioche

2016 ◽  
Vol 07 (01) ◽  
pp. 024-026
Author(s):  
Nikolaos V. Chrysanthos ◽  
Evagelia Anagnostopoulou ◽  
Eleni Triga ◽  
Stratigoula Sakelariou ◽  
Pinelopi Korkolopoulou

AbstractNeuroendocrine neoplasms of the gastric tube are less common than adenocarcinomas. Topography includes stomach, small intestine, Vater ampulla, and gross intestine. They are graded as neuroendocrine tumors grade I and II (NETs GI and GII) and neuroendocrine carcinomas GIII based on Ki-67 index and mitotic count.[1] Endoscopic treatment for GI NETs ≤1 cm that does not extend beyond the submucosal layer and does not demonstrate lymph node metastasis is recommended. Tumors ≥2 cm, with lymph node metastasis, are indicated for surgical treatment. The treatment strategy for tumors between 10 and 20 mm in size remains controversial.[2] We present a rare case of a 60-year-old male patient with end-stage renal failure who underwent a screening pretransplantation endoscopic control. Colonoscopy had no pathological findings. Gastroscopy reveals an abnormal mucosa in the anterior upper part of the duodenal bulb that was described as a micronodular mucosa and a central nodule of 6 mm with erythematous mucosa. Histology of the micronodular mucosa reveals a heterotopic gastric mucosa and a small hyperplastic polyp. Biopsies from the nodule reveal a carcinoid tumor (NET GI). Immunohistochemistry: Positive chromogranin levels, low mitotic index (1/10 HPF), and Ki-67 index <1% [Figure 2]. Gastrin levels were normal and chromogranin levels were abnormal (314 ng/ml, ULN <120 ng/ml). Spiral tomography of the thorax and the abdomen were normal. Endoscopic submucosal dissection is indicated for small NETs (≤1 cm). Laparoscopic and endoscopic cooperative surgery is a novel method, but the experience is limited. Surgery is the best choice for large NETs (>2 cm) and those of the duodenal bulb with histological extensions and the lack of assessing depth invasion.


2014 ◽  
Vol 79 (5) ◽  
pp. 716 ◽  
Author(s):  
Crispin Musumba ◽  
Rebecca Sonson ◽  
Nicholas Tutticci ◽  
Kavinderjit Nanda ◽  
Michael J. Bourke

Sign in / Sign up

Export Citation Format

Share Document